Reagenzgläser
Vesalius Biocapital

A European life sciences venture capital investor

.

About us

News

Vesalius News

Memo Therapeutics on WTC 2025
read more
Memo Therapeutics: Study Transcytosis
read more
Rejuvenate Biomed: First Patient
read more
.

xxnoxx_zaehler